Health department assures public that Enalapril 5mg remains safe despite 10mg recall
Mohale urged patients not to panic or stop their medication.
In response to a recent recall of certain batches of Enalapril 10mg tablets, the South African Health Department has reassured the public that the 5mg version of the medication remains safe for continued use. The Department of Health clarified on Thursday that the recall does not affect the 5mg tablets currently supplied to public healthcare facilities.
Dr Foster Mohale, a spokesperson for the health department, emphasized that patients do not need to stop taking their medication due to the recall. The affected 10mg tablets were manufactured by Arya Pharma and were only approved as a short-term substitute while the department's usual supplier, Austell Pharmaceuticals, experienced production delays.
The South African Health Products Regulatory Authority (SAHPRA) confirmed that the 5mg tablets meet all necessary standards. Mohale urged patients to continue taking their medication as prescribed and not to panic, as all 5mg batches supplied to public facilities have been confirmed to meet required quality and registration standards.
The health department requested provinces and healthcare facilities to share this information with their staff to prevent unnecessary concern or disruption to patients.
Written by urgent.news from The Citizen's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
